Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction
Abstract
OBJECTIVE: To investigate the effects of long-term levothyroxine (LT4) suppressive therapy on the heart and the effects of beta-blockade on cardiac functions. DESIGN: Twelve female patients receiving LT4, selected from a group of patients with TSH levels of 0.1-0.4 microU/ml, were evaluated. The control group consisted of 11 healthy subjects and 12 patients with TSH levels <0.05 microU/ml. METHODS: Cardiac evaluation consisted of a 12-lead electrocardiogram and an echocardiographic study. Left ventricular mass index (LVMI), isovolumetric relaxation time (IVR), left ventricular end systolic (LVESD) and diastolic diameters, early (VE) and late (VA) diastolic flow velocities and fractional shortening were evaluated. Exercise capacity was assessed with a bicycle ergometer. Both work load and maximal exercise time were measured. Atenolol was given to the patient group at a dosage of 50 mg/day for 3 months and evaluations were repeated. RESULTS: On basal evaluations, LVMI (96+/-17 vs 78+/-21 g/m(2)) and IVR (101+/-9 vs 91+/-4 ms) were found to be increased in the patients taking LT4 (P<0.01). LVESD was also lower than controls (P<0.05). A decrease in VE and an increase in VA were also observed in the patients (P<0.01). IVR decreased after atenolol (92+/-10 vs 101+/-9 ms, P<0.05). LVMI decreased and VE and VA improved but did not reach statistical significance after beta-blockade. Baseline work load and maximal exercise duration were significantly lower in the patients and improvements were observed after atenolol treatment. CONCLUSIONS: These results indicated that cardiac dysfunction may occur even when TSH is suppressed to 0.1-0.4 microU/ml with LT4. beta-blockade improved the cardiac functions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some studies suggest that cardioselective β-blockers or treatment of SHyper with ATDs may improve symptoms, heart rate and supraventricular arrhythmias in patients with grade 2 SHyper.
“Some studies suggest that cardioselective β-blockers [47,48] or treatment of SHyper with ATDs [46,67] may improve symptoms, heart rate and supraventricular arrhythmias in patients with grade 2 SHyper.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [48]
Cites
Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430 · see citing works
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499 · see citing works
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300 · see citing works
Polikar, R., Burger, A. G., Scherrer, U., & Nicod, P. (1993) · Circulation · doi:10.1161/01.cir.87.5.1435 · Cited by 475 · see citing works
Thyroid hormone and the cardiovascular system
Klein, I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90531-h · Cited by 370 · see citing works
Biochemical basis of thyroid hormone action in the heart.
Dillmann, W. H. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90530-q · Cited by 338 · see citing works
Levothyroxine Therapy in Patients with Thyroid Disease
Mandel, S. J., Brent, G. A., & Larsen, P. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00009 · Cited by 324 · see citing works
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
Özata, M., Suzuki, S., Miyamoto, T., Liu, R., Fierro-Renoy, F., & DeGroot, L. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027262 · Cited by 251 · see citing works
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8302 · Cited by 245 · see citing works
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.
Biondi, B., Fazio, S., Carella, C., Amato, G., Cittadini, A., Lupoli, G., Saccà, L., Bellastella, A., & Lombardi, G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8345037 · Cited by 237 · see citing works
Papini, E., Petrucci, L., Guglielmi, R., Panunzi, C., Rinaldi, R., Bacci, V., Crescenzi, A., Nardi, F., Fabbrini, R., & Pacella, C. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4615 · Cited by 194 · see citing works
Fadel, B. M., Ellahham, S. H., Lindsay, J. M., Ringel, M. D., Wartofsky, L., & Burman, K. D. (2000) · Clinical Cardiology · doi:10.1002/clc.4960230605 · Cited by 169 · see citing works
Mercuro, G. G., Panzuto, M., Bina, A., Leo, M., Cabula, R., Petrini, L., Pigliaru, F., & Mariotti, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6298 · Cited by 162 · see citing works
Thyroxine Suppressive Therapy in Patients with Nodular Thyroid Disease
Gharib, H., & Mazzaferri, E. L. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-5-199803010-00008 · Cited by 162 · see citing works
Mintz, G. L., Pizzarello, R. A., & Klein, I. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-146 · Cited by 156 · see citing works
Biondi, B., Fazio, S., Cuocolo, A., Sabatini, D., Nicolai, E., Lombardi, G., Salvatore, M., & Saccà, L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954019 · Cited by 142 · see citing works
Biondi, B. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1028 · Cited by 137 · see citing works
Toft, A. D., & Boon, N. A. (2000) · Heart · doi:10.1136/heart.84.4.455 · Cited by 122 · see citing works
Fazio, S., Biondi, B., Carella, C., Sabatini, D., Cittadini, A., Panza, N., Lombardi, G., & Saccà, L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608283 · Cited by 119 · see citing works
Recognition and management of cardiovascular disease related to thyroid dysfunction
Ladenson, P. W. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90532-i · Cited by 111 · see citing works
Shapiro, L. E., Sievert, R., Ong, L., Ocampo, E. L., Chance, R. A., Lee, M., Nanna, M., Ferrick, K. J., & Surks, M. I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4155 · Cited by 109 · see citing works
Diagnosing Diastolic Heart Failure
Kraaij, D. J. W. V., van Pol, P. E. J., Ruiters, A. W., de Swart, J. B. R. M., Lips, D. J., Uszko‐Lencer, N. H. M. K., & Doevendans, P. A. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00020-x · Cited by 58 · see citing works
Subclinical Hyperthyroidism: Possible Danger of Overzealous Thyroxine Replacement Therapy
Ross, D. S. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65409-3 · Cited by 58 · see citing works
Editorial: Thyroid Hormone--Targeting the Heart
Klein, I. L., & Ojamaa, K. (2001) · Endocrinology · doi:10.1210/endo.142.1.7986 · Cited by 52 · see citing works
Evidence of Hyperthyroidism in Apparently Euthyroid Patients Treated With Levothyroxine
Banovac, K. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040043008 · Cited by 41 · see citing works
Diastolic Dysfunction in Arterial Hypertension
SIMONE, G. D., & Palmieri, V. (2001) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.00827.x · Cited by 40 · see citing works
Suppressive Therapy with Levothyroxine for Euthyroid Diffuse and Nodular Goiter.
Güllü, S., GÜRSES, M. A., Başkal, N., Uysal, A. R., KAMEL, A. N., & Erdoğan, G. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.221 · Cited by 24 · see citing works
Degree of Thyrotropin Suppression in Differentiated Thyroid Cancer without Recurrence or Metastases
Kamel, N., Güllü, S., ILGIN, S. D., Çorapçıoğlu, D., CESUR, V., Uysal, A. R., Başkal, N., & Erdogan, G. (1999) · Thyroid · doi:10.1089/thy.1999.9.1245 · Cited by 23 · see citing works
Self-citationAssessment of ventricular diastolic function.
Smiseth, O. A. (2001) · PubMed · Cited by 19 · see citing works
Diastolic function in hypertension
Phillips, R. A., & Diamond, J. A. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0071-4 · Cited by 14 · see citing works
Diastolic dysfunction: insights into pathophysiology and pharmacotherapy
Redfield, M. M., & Maniu, C. V. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.6.997 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · see citing works
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323 · see citing works
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286 · see citing works
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98 · see citing works
Thyroid Hormone Suppression Therapy
Biondi, B., & Cooper, D. S. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.10.008 · Cited by 81 · see citing works
Papi, G., Pearce, E. N., Braverman, L. E., Betterle, C., & Roti, E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.004 · Cited by 39 · see citing works
- Authors
- Gullu, S., Altuntas, F., Dincer, I., Erol, C., & Kamel, N.
- Affiliations
- Ankara University (TR)
- ORCID
- Kamel, N
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 150
- Issue
- 5
- Pages
- 655-661
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2111593555
- Cited by
- 57
- References
- 31
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 6 · 2012: 5
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- TSH suppression, levothyroxine, beta-adrenergic blockade, atenolol, diastolic dysfunction, left ventricular mass, left ventricular hypertrophy, isovolumic relaxation time, exercise capacity, cardiac function, subclinical hyperthyroidism
- MeSH terms
- Adrenergic beta-Antagonists, Adult, Atenolol, Blood Flow Velocity, Coronary Circulation, Diastole, Echocardiography, Exercise Test, Female, Heart, Heart Rate, Humans, Middle Aged, Myocardial Contraction, Myocardium, Physical Endurance, Stroke Volume, Systole, Thyrotropin, Thyroxine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review